2m 2m 2m 2m 2m 2m 2m
CRESCENT BIOPHAR (CBIO)
NASDAQ
$16.71-$0.44 (-2.55%)
Price as of Aug 21, 2026 7:56 PM EDT- $292.5MMarket Cap
- 13.88%1-Year Change
- BiotechnologyIndustry
CRESCENT BIOPHAR (CBIO)
$16.71-$0.44 (-2.55%)
CBIO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $17.15 | ||
Change | +$0.92 (+5.67%) | ||
Open | $16.39 | ||
High | $17.19 | ||
Low | $16.03 | ||
Previous Close | $16.23 | ||
Volume | 218,388 | ||
30-Day Average Volume | 229,798 | ||
1-Week Change | 0.06% | ||
1-Month Change | 3.06% | ||
1-Year Change | 13.88% | ||
3-Year Change | 110.91% | ||
5-Year Change | -70.91% | ||
Fundamentals | |||
Shares Outstanding | 37.1M | ||
Total Assets | $182.8M | ||
Market Cap | $292.5M | ||
Enterprise Value | $120.9M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$24.8M | ||
Free Cash Flow | -$19.5M | ||
EBIT | -$24.8M | ||
EBITDA | -$24.8M | ||
Net Working Capital | $160.5M | ||
EPS | N/A | ||
Enterprise Value/EBITDA | -5 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 4 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | -33 | ||
Price/Operating Cash Flow | -33 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 15 | ||
Last Split Date | 10/31/2023 | ||
Earnings & Revenue
Annual Dividend Yield